Based on these evidence, we demonstrated that bypassing Mcl-1 mediated resistance, represents a useful strategy to sensitize leukemic cell lines and CLL to apoptosis. This evidence concerns the gene MCL1 and B-cell chronic lymphocytic leukemia.